NasdaqCM - Delayed Quote USD
CASI Pharmaceuticals, Inc. (CASI)
2.0000
+0.0600
+(3.09%)
As of April 23 at 4:00:00 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-29,224
-29,224
-19,967
-21,088
-26,842
Investing Cash Flow
11,244
11,244
-9,673
31,159
-20,691
Financing Cash Flow
15,434
15,434
-907
-3,267
29,642
End Cash Position
13,468
13,468
17,083
47,112
38,704
Income Tax Paid Supplemental Data
--
--
1,807
--
--
Interest Paid Supplemental Data
--
--
--
62
42
Capital Expenditure
-240
-240
-2,241
-5,612
-15,500
Issuance of Capital Stock
15,000
15,000
--
--
32,500
Issuance of Debt
--
--
--
4,001
709
Repayment of Debt
--
--
--
-4,001
-1,548
Repurchase of Capital Stock
--
--
-278
-3,267
--
Free Cash Flow
-29,464
-29,464
-22,208
-26,700
-42,342
12/31/2021 - 6/12/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ESLA Estrella Immunopharma, Inc.
0.9101
-5.20%
ADAG Adagene Inc.
1.5094
+5.55%
IPHA Innate Pharma S.A.
2.0000
+1.52%
2126.HK JW (Cayman) Therapeutics Co. Ltd
1.610
-1.23%
1875.HK TOT BIOPHARM-B
2.050
+12.64%
BINV.ST BioInvent International AB (publ)
29.00
-0.34%
IMAB I-Mab
0.8400
-2.44%
3MM.F Advicenne S.A.
1.7000
+0.24%
ADXN Addex Therapeutics Ltd
7.60
+4.11%
IUGNF Imugene Limited
0.0200
0.00%